GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Development of a clinically relevant mouse model of lung cancer cachexia to study pathoetiology and therapeutic strategies

$173,208
Michael J Toth · University Of Vermont & St Agric College · R21 · FY2024 · CA

Project 4: Model-Based Dosimetry and Imaging for PDT

$173,201
Brian William Pogue · Massachusetts General Hospital · P01 · FY2015 · CA

Epigenetic drivers of cancer progression

$172,961
Andrew P Feinberg · Johns Hopkins University · R01 · FY2021 · CA

Elucidating p53 transcriptional networks involved in pancreatic cancer suppressio

$172,957
Laura D Attardi · Stanford University · R21 · FY2012 · CA

Translational Research Training in Gastroenterology and Hepatology

$172,924
Maria Teresa Abreu · University Of Miami School Of Medicine · T32 · FY2022 · DK

Selective sensitization of pancreatic tumor cells to chemotherapy

$172,921
Erasmus Schneider · Wadsworth Center · R21 · FY2011 · CA

Defining the Role for A Lipid Kinase in the Progression of Pancreatic Cancer

$172,913
Kun Ling · Mayo Clinic Rochester · R21 · FY2016 · CA

Dissecting ALK4 Function in Cancer Progression

$172,913
Gerard C Blobe · Duke University · R21 · FY2016 · CA

Supramolecular matrix materials for prostate cancer cell biology

$172,830
Donald James Vander Griend · University Of Illinois At Chicago · R21 · FY2018 · CA

The role of Hedgehog in hematopoiesis and leukemogenesis

$172,800
Inga Hofmann Zhang · Boston Children'S Hospital · K08 · FY2010 · CA

GI Tumor Program

$172,751
Giuseppe Giaccone · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Coded-aperture Compton scatter imaging for real-time tumor motion tracking during ablative radiotherapy

$172,460
Bernard L Jones · University Of Colorado Denver · R21 · FY2021 · CA

Role of N-Cadherin in Pancreatic Tumor Microenvironment

$172,434
Keith R Johnson · University Of Nebraska Medical Center · U54 · FY2012 · CA

Experimental Pathology Core

$172,426
Mark Redston · Dana-Farber Cancer Inst · P01 · FY2007 · CA

Dual recombinase models of pancreatic cancer

$172,369
Elliott Scott Seeley · University Of California, San Francisco · R21 · FY2016 · CA

Preclinical evaluation of a targeted Bmi1 inhibitor in pancreatic cancer

$172,340
Kenneth P Olive · Columbia University Health Sciences · R21 · FY2015 · CA

Mechanism-Based Design of Combination Therapies for Pancreatic Cancer

$172,309
Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2012 · CA

Targeting Akt with substrate mimetic antagonists

$172,249
Juan R Del Valle · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2013 · CA

TARGETED DELIVERY OF GENES TO ANGIOGENIC VASCULATURE

$172,223
University Of Texas Md Anderson Can Ctr · R01 · FY2002 · CA

Role of Protein Kinase D in Pancreatic Cancer

$172,125
Peter Storz · Mayo Clinic Jacksonville · R21 · FY2009 · CA

Non-invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer

$172,097
Charles Scott Craik · University Of California, San Francisco · R21 · FY2015 · CA

UNMC Eppley Cancer Center Support Grant

$172,091
Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2007 · CA

CA: Administrative Core

$171,899
Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2012 · CA

Detection of 5-hmC as a Novel Screening Biomarker for Pancreatic Cancer

$171,851
Wei Zhang · Northwestern University At Chicago · R21 · FY2016 · CA

Develop and Characterize a Novel Animal Model of Pancreatic Cancer

$171,825
Baoan Ji · University Of Tx Md Anderson Can Ctr · R21 · FY2011 · CA